Category: #HERCULES Study

Featured image for “Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis”

Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Paris, April 8, 2025. The New…

Stuart Schlossman

Categories

Latest Blog Posts